Companies


THE PLACE WHERE NEW TECHNOLOGY BUSINESSES GROW



  • AJES Life Sciences, LLC

    • CEO
    • AJES Life Sciences, LLC is a Research & Development contract research company that provides preclinical and toxicology services for developers of new pharmaceuticals, specifically, vitro and in vivo clinical efficacy, clinical toxicology and mode of action analysis for its clients. AJES will be locating to the Long Island High Technology Incubator in Stony Brook and will create nine net new jobs while investing $3.69 million.






  • Alpha-1 Biologics Corporation (A1Bio)

    • Chief Scientific Officer
    • Alpha-1 Biologics Corporation (A1Bio) was founded in June, 2011 to develop products for immune cell replenishment (pre- and post-cancer therapy, HIV/AIDS), HDL and LDL regulation (cardiovascular disease), and diagnostic testing (CD4 enumeration, leukemia).






  • Applied DNA Sciences, Inc.

    • Chairman, President & CEO
    • Applied DNA Sciences delivers anti-counterfeit solutions, supply chain protection, brand authentication, and evidentiary solutions for law-enforcement like no other. Our unique applications combat product diversion, and offer award-winning programs against cash-in-transit crimes, all using the proven forensic power of DNA.






  • ASET Therapeutics LLC

    • Chief Scientific Officer
    • ASET Therapeutics discovers and develops therapeutics targeting Splice-Activated Oncogenes. Our vision is to provide precision medicine solutions that enable oncologists to screen cancer patients for tumors driven by Splice-Activated-Oncogenes and prescribe selective treatments.






  • Biocogent, LLC

    • President
    • Biocogent, LLC is a premier provider of high technology products and services to the personal care and cosmetic industries. Rooted in biotechnology, Biocogent utilizes pioneering technology in research, development, and manufacturing to provide innovative value-driven functional ingredients and services to its customers.






  • Blood Cell Technologies, LLC

    • Founder and CEO
    • Blood Cell Technologies, LLC is an early-stage research and development biotechnology company with a focus on identifying, validating, and commercializing novel drug targets and compounds that may be used to diagnose or treat blood cell disorders. The initial focus of the company is development of a first-in-class redox-inhibiting compound to enhance platelet production in humans.






  • Chroma Research Labs, Inc.

    • Sr. Director Quality
    • Mathew Chamakkala is a Pharmaceutical professional for the last 33 years. He is the founder and owner of Chroma Research Labs, a firm focused on HPLC Method Validations and other lab-related services. Previously, Mathew was Director of R&D at Contract Pharmacal Corporation which develops, manufactures and packages premium pharmaceuticals, over-the-counter drugs and dietary supplements.






  • Codagenix, Inc.

    • President
    • Codagenix utilizes our breakthrough platform technology termed SAVE (Synthetic Attenuated Virus Engineering) to construct live-attenuated viral vaccines against multiple targets. All live-attenuated vaccines that are currently used in the clinic were developed using a trial-and-error based method developed in the 1880s, pre-dating the discovery of the DNA double helix.






  • Guided Interventions, Inc.

    • President and CEO
    • Guided Interventions was founded by Dr. Pollman and Reinhard Warnking in 2011 with the vision to create a medical device company developing enabling technologies designed to maximize efficacy, minimize risk and reduce the cost of interventional procedures.






  • iCell Gene Therapeutics LLC

    • Chief Scientific Officer
    • iCell Gene Therapeutics is focused on creating novel immunotherapies for cancer treatment through the development of Chimeric Antigen Receptor (CAR) therapies that target and destroy multiple types of cancer. Our goal is to eradicate these devastating diseases, and to offer patients with resistant cancer a chance at a cure.






  • ImmunoMatrix, LLC

    • Founder and President
    • The Key to Global Immunization. ImmunoMatrix enables patients to be vaccinated at minimal cost and discomfort. Using a small, disposable patch, ImmunoMatrix makes advanced medical personnel and needles obsolete.






  • IMSzema Solutions

    • CEO
    • Consultants to the Pharmaceutical Industry.






  • MarrowSource Therapeutics International, LLC

    • Chief Scientific Officer
    • MarrowSource seeks to identify and develop small molecules or proteins which can be used to rapidly expand human hematopoietic stem cells in vitro for transplantation into patients in need of regenerative stem cell therapy.






  • Medicon Pharmaceuticals, Inc.

    • President
    • Medicon Pharmaceuticals Inc. is developing novel agents for the treatment of cancer and inflammation.






  • MindWick Inc.

    • CEO
    • MindWick’s mission is to develop engaging, innovative, easily deployable educational products and services for the STEM market segment.






  • Mobileware, Incorporated

    • Chief Executive Officer
    • Mobileware, Inc. focuses on producing high quality Mobile Apps to provide personal and business users instant access to their information anytime, anywhere. Email: support@mobilewareinc.com






  • Neomatrix Therapeutics, Inc.

    • President
    • Neomatrix Therapeutics is seeking novel solutions for the limitation of dermal injury, the enhancement of wound healing, and the promotion of nonscar healing and tissue regeneration.






  • P&L Technical Management Solutions

    • President and Treasurer
    • P&L Technical Management Solutions (PLTMS) is a Minority Owned (Hispanic) Small Business that supports client strategic business initiatives and technology development for the Commercial and Aerospace & Defense Market Space including Department of Defense (DoD), Department of Homeland Security (DHS), and highly regulated civilian marketplace.






  • PHD Skin Care LLC

    • Chief Executive Officer
    • PHD Skin Care is an emerging global brand focused on developing topical products for the OTC drug, sun, and skin care markets. The brand utilizes its patented and proprietary Never Miss A Spot wand technology to facilitate homogenous self-application of topical formulas to the harder to reach areas of the back and shoulders. Products are available on HSN, and will be available in 1,000 retail stores in 2016.






  • Plant Genetic Engineering, Inc.

    • Founder & CEO
    • PGE is an early stage, biotechnology, private company located at The Long Island High Technology Incubator (LIHTI) next to Stony Brook University. We are the owners of a new technology called self Biological Nitrogen Fixation, sBNF- a new generation of man-made Ag Tech crops. We are helping to feed the world, making it safer and cleaner place to live.






  • PolyNova CardioVascular, Inc.

    • Operations Manager
    • PolyNovaCV is a start-up medical device company developing innovative minimally invasive devices for the treatment of cardiovascular disease using synthetic biomaterials.






  • Progen Inc.

    • President
    • The company’s mission is to develop diagnostic biomarkers that can guide physicians in choosing the most effective therapeutic approach (companion diagnostics for cancer).






  • QB Sonic, Inc.

    • CEO
    • QB Sonic is developing innovative non-invasive ultrasound stimulators for enhancing bone, joint and soft-tissue healing.






  • Saniteq LLC

    • Managing Director
    • Saniteq researches, designs, develops, manufactures and markets unique patented computer based industrial control instruments and commercial products.






  • Softheon, Incorporated

    • President and Chief Executive Officer
    • Empowering the nation's first state health benefit exchange since 2008, Softheon's vision and strategic direction address healthcare payer, provider, and government agencies' goal of meeting Affordable Care Act (ACA) milestones. Softheon provides HIX Integration, Direct Enrollment, Premium Billing, and Edge Server solutions for insurance carriers of all sizes participating in Federal and State Health Insurance Exchange (HIX) Marketplaces.






  • Stony Brook Building Science, LLC

    • President
    • The company will provide best in class analytics for architects and engineers in the building energy modeling and controls modeling.






  • SynchroPET Inc.

    • Founder/CEO
    • SynchroPET is a biomedical device manufacturer with a platform P.E.T. Scanner Technology that enables them to build miniaturized PET Scanners that can retrofit into MRI devices.






  • TargaGenix

    • President & CEO
    • TargaGenix is a biopharmaceutical company developing novel cancer compounds that target both the bulk tumor and cancer stem cells.






  • Theragnostic Technologies Inc.

    • Founder
    • Theragnostic Technologies Inc. focuses on research, design, development, and marketing of high performance multifunctional materials and devices. It is currently developing nanotechnology-enabled contrast agents, therapeutic and drug delivery platforms, and biomedical devices.






  • Traverse Biosciences Inc.

    • Founder and CEO
    • Traverse Biosciences is commercializing novel drug candidates for the treatment of inflammatory diseases and related conditions affecting humans and companion animals.






  • Vascular Simulations, LLC

    • President and CFO
    • Introducing the worlds first Vascular Replication System® powered by the True-flow® Pulsatile Flow Generator. The first system that replicates the cardiac cycle and blood flow in customizable vasculature that can be recreated from CT, MR or rotational angiography images. For medical device development and testing, physician education and training.






  • Vitatex, Inc.

    • President
    • Vitatex is focused on advance personalized medicine with tests of invasive circulating tumor cells (iCTCs) that provide better information about the metastatic potential of a patient’s cancer to improve treatment and reduce health care costs. The company’s unique advantage stems from its patented approach that captures iCTCs directly linked to the metastatic process.






  • Zortag, Inc.

    • President and CEO
    • By using a cell phone or image capture device (e.g. tablet, barcode scanner, or a computer) and utilizing a unique, impossible to clone label affixed to an article, and a secure database, Zortag's anti-counterfeiting solutions prevent product counterfeiting, product diversions, product overruns, and product theft.